Name:  ___.                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___ has class III morbid obesity with 
weight of 244.7 pounds as of ___ with her initial screen 
weight of 241.5 pounds on ___, height of 61.5 inches and BMI 
of 45.5.  Her previous weight loss efforts have included Weight 
Watchers, ___, the ___, "I Diet" (lost 12 
pounds), ___ diet, RD and PCP visits losing up to 60 
pounds but her weight loss attempts at failed to produce 
significant and/or last results. 
She has not taken prescription weight loss medications (had been 
discussed with her PCP previously but no pharmacotherapy 
initiated) or used over-the-counter ephedra-containing appetite 
suppressants/herbal supplements.  She was also advised to 
consider CBT (cognitive behavioral therapy) by her PCP.  She
stated that her lowest adult weight was 145 pounds at the age of 
___ and she is at her highest weight of 245 pounds.  She weighed 
245 pounds ___ years ago, 293 pounds ___ years ago and 235 pounds 
one year ago.  She stated that she has been struggling with 
weight since the age of ___ and cites as factors contributing to
her excess weight large portions, convenience eating, genetics, 
emotional eating ___ times a month, boredom and lack of 
exercise. She does some walking but has not started an exercise 
routine yet.  She denied history of eating disorders , no 
anorexia, bulimia, diuretic or laxative abuse and she denied 
binge eating. She does not have a clinical diagnosis of 
depression except for
situational and reactive and she has not seen a therapist nor 
has she been hospitalized for mental health issues and she is 
not on any psychotropic medications.

 
Past Medical History:
1)  hypertension
2)  type 2 diabetes with hemoglobin A1c of 6.1%
3)  hyperlipidemia
4)  history of thyroid nodule
5)  hepatic steatosis by ultrasound study in ___
6)  history of gallstones
7)  vitamin D deficiency
8)  hyperuricemia

Her surgical history is noted for:

1)  laparoscopic cholecystectomy ___
2)  hysteroscopy in ___ fibroid uterus/history of 
    miscarriage at 22 weeks
3)  cryotherapy of the cervix

 
Social History:
___
Family History:
Her family history is noted for father deceased age ___, history 
of stroke, hypertension; mother living age ___ with diabetes, 
COPD, hyperlipidemia, heart disease, and arthritis; she has 3 
brothers alive and well and one sister alive and well.  
 
Physical Exam:
Exam on discharge:

P/E:
Vital Signs: 98.4 PO, 109 / 68, 77, 18, 96 RA 
GEN: WD, WN in NAD
HEENT: NCAT, EOM grossly intact, anicteric
CV: RRR
PULM:  no respiratory distress
ABD: soft, NT, ND, no mass, no hernia, dressings c/d/I 
EXT: WWP
NEURO: A&Ox3, no focal neurologic deficits
 
Pertinent Results:
___ 10:42AM BLOOD WBC-10.7* RBC-4.20 Hgb-13.2 Hct-39.3 
MCV-94 MCH-31.4 MCHC-33.6 RDW-12.5 RDWSD-42.9 Plt ___
 
Brief Hospital Course:
The patient presented to pre-op on ___. The patient 
was evaluated by anaesthesia and surgery and was taken to the 
operating room where she underwent a laparoscopic sleeve 
gastrectomy for obesity. There were no adverse events in the 
operating room; please see the operative note for details. Pt 
was extubated, taken to the PACU until stable, then transferred 
to the ward for observation.  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Lisinopril 10 mg PO DAILY 
2. MetFORMIN (Glucophage) 1000 mg PO DAILY 
3. Simvastatin 20 mg PO QPM 
4. Multivitamins W/minerals 1 TAB PO DAILY 
5. calcium citrate-vitamin D3 unknown mg oral DAILY 
6. Hydrochlorothiazide 25 mg PO DAILY 
7. Vitamin D ___ UNIT PO DAILY 
8. fish oil-dha-epa ___ mg oral DAILY 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
Do not exceed 3000 mg per 24 hour period. 
RX *acetaminophen 650 mg/20.3 mL 20 mL by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
2.  Docusate Sodium 100 mg PO BID:PRN constipation 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day Disp 
#*300 Milliliter Refills:*0 
3.  Famotidine 20 mg PO BID 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
4.  OxycoDONE Liquid ___ mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL ___ mg by mouth every four (4) hours 
Refills:*0 
5.  MetFORMIN (Glucophage) 500 mg PO DAILY
   *Patient does not check blood sugars at home. As a result, 
instructed to hold home metformin until follow up.   
6.  calcium citrate-vitamin D3 unknown  oral DAILY  
7.  fish oil-dha-epa ___ mg oral DAILY  
8.  Lisinopril 10 mg PO DAILY  
9.  Multivitamins W/minerals 1 TAB PO DAILY  
10.  Simvastatin 20 mg PO QPM  
11.  Vitamin D ___ UNIT PO DAILY  
12. HELD- Hydrochlorothiazide 25 mg PO DAILY  This medication 
was held. Do not restart Hydrochlorothiazide until you discuss 
with Dr. ___ your primary care provider.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity
Diabetes Mellitus

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Please call your surgeon or return to the Emergency Department 
if you develop a fever greater than ___ F, shaking chills, chest 
pain, difficulty breathing, pain with breathing, cough, a rapid 
heartbeat, dizziness, severe abdominal pain, pain unrelieved by 
your pain medication, a change in the nature or severity of your 
pain, severe nausea, vomiting, abdominal bloating, severe 
diarrhea, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness, swelling from your 
incisions, or any other symptoms which are concerning to you.
Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 
Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.
6. Please hold hydrochlorothiazide at this time; please notify 
your primary care provider of this medication change 
immediately.  Also, monitor your blood pressure daily and report 
elevated or low readings to your primary care provider.  Please 
seek immediate medical attention should you develop a severe 
headache, weakness, difficulty walking or talking, dizziness or 
any other symptoms that are concerning to you.
7.  Please take half your normal metformin dose and monitory 
your blood sugars three times per day; report elevated or low 
readings to your primary care provider ___.  Also, 
please notify your primary care provider of this medication 
change immediately.
*Patient does not check her blood sugars at home. As a result, 
at time of discharge instructed to hold home metformin until 
follow up with Dr. ___. 
Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.
Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___